Clinical Trial Update: A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab [Phase 3]

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a Phase 3 study evaluating Upadacitinib in adults with moderate-to-severe Atopic Dermatitis who have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING